Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

休市中 07-11 16:00:00 EDT

1.74

-0.07

-3.69%

最高1.81	最低1.70	成交量4,886
今开1.75	昨收1.81	日振幅6.07%
总市值1.61亿	流通市值1.03亿	总股本9,216万
成交额8,586	换手率0.01%	流通股本5,922万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":1.7432,"timestamp":1752264000000,"preClose":1.81,"halted":0,"volume":4886,"delay":0,"floatShares":59222661,"shares":92164948,"eps":-0.63191,"marketStatus":"休市中","change":-0.0668,"latestTime":"07-11 16:00:00 EDT","open":1.75,"high":1.81,"low":1.7001,"amount":8585.765194,"amplitude":0.060718,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.63191,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1571284800000,"exchange":"NASDAQ","adjPreClose":1.81,"preHourTrading":{"tag":"盘前","latestPrice":1.75,"preClose":1.81,"latestTime":"09:21 EDT","volume":325,"amount":568.213035,"timestamp":1752240085591},"volumeRatio":0.7863396268892824},"requestUrl":"/m/hq/s/IPHA","defaultTab":"news","newsList":[{"id":"2550933675","title":"Innate Pharma盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550933675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550933675?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:57","pubTimestamp":1752177479,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时57分，Innate Pharma股票出现异动，股价快速上涨5.20%。截至发稿，该股报1.81美元/股，成交量9012股，换手率0.01%，振幅5.23%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.49%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711035759a443219e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711035759a443219e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2548012395","title":"Innate Pharma盘中异动 下午盘股价大跌7.57%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548012395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548012395?lang=zh_cn&edition=full","pubTime":"2025-07-01 02:30","pubTimestamp":1751308258,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日02时30分，Innate Pharma股票出现异动，股价大幅下跌7.57%。截至发稿，该股报1.71美元/股，成交量6830股，换手率0.01%，振幅3.06%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070102305995318dcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070102305995318dcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2546751824","title":"Innate Pharma盘中异动 临近收盘大幅拉升7.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546751824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546751824?lang=zh_cn&edition=full","pubTime":"2025-06-27 04:27","pubTimestamp":1750969635,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日04时27分，Innate Pharma股票出现异动，股价快速上涨7.60%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Adial Pharmaceuticals, Inc、Vor Biopharma Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1739.43%、324.29%、228.64%，振幅较大的相关个股有Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Moolec Science Sa C/Wts ，振幅分别为98.85%、90.04%、61.67%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627042715a71f652c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627042715a71f652c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2545755417","title":"Innate Pharma盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545755417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545755417?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:51","pubTimestamp":1750686668,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时51分，Innate Pharma股票出现波动，股价急速下跌5.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为1195.04%、1081.40%、286.92%，振幅较大的相关个股有Impact Biomedical, Inc.、Immatics N V C/Wts 01/07/2025 、Indaptus Therapeutics, Inc.，振幅分别为129.80%、71.02%、64.31%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062321510895281bc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062321510895281bc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2543963265","title":"Innate Pharma盘中异动 下午盘急速下跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543963265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543963265?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:10","pubTimestamp":1749841833,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日03时10分，Innate Pharma股票出现异动，股价大幅跳水5.29%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Vaxart, Inc. - Common Stock、Psyence Biomedical Ltd C/Wts 25/01/2029、Lineage Cell Therapeutics, Inc.涨幅较大，Nucana Plc、Alzamend Neuro, Inc.、Onconetix, Inc.较为活跃，换手率分别为1715.38%、83.31%、53.61%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、凯信远达、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为78.14%、65.84%、54.97%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614031033a708189d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614031033a708189d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2539279320","title":"Innate Pharma盘中异动 股价大跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539279320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539279320?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:04","pubTimestamp":1748621046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时04分，Innate Pharma股票出现异动，股价急速下跌6.29%。截至发稿，该股报2.06美元/股，成交量5680股，换手率0.01%，振幅0.90%。Innate Pharma股票所在的生物技术行业中，整体跌幅为3.91%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053100040695087195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053100040695087195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2535376020","title":"Innate Pharma盘中异动 快速拉升7.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535376020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535376020?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:36","pubTimestamp":1747229761,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时36分，Innate Pharma股票出现波动，股价大幅上涨7.35%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Septerna, Inc.、Humacyte Inc C/Wts 27/08/2026 、蓝鸟生物涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2141.61%、1347.00%、1223.27%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nucana Plc、Quoin Pharmaceuticals Ltd，振幅分别为46.33%、23.40%、20.28%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213601a6df09c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213601a6df09c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2534208282","title":"Innate Pharma盘中异动 早盘大幅下跌5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534208282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534208282?lang=zh_cn&edition=full","pubTime":"2025-05-12 22:24","pubTimestamp":1747059893,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日22时24分，Innate Pharma股票出现异动，股价大幅下跌5.68%。Innate Pharma股票所在的生物技术行业中，整体涨幅为3.17%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为537.45%、94.39%、63.53%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Fortrea Holdings Inc.，振幅分别为57.09%、54.64%、43.58%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512222454a47b858f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512222454a47b858f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2534348114","title":"Innate Pharma盘中异动 早盘快速拉升7.14%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534348114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534348114?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:56","pubTimestamp":1746802567,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时56分，Innate Pharma股票出现波动，股价急速拉升7.14%。截至发稿，该股报2.55美元/股，成交量2.789万股，换手率0.03%，振幅6.72%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.06%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509225608aa2c8954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509225608aa2c8954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2533133932","title":"Innate Pharma盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533133932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533133932?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:36","pubTimestamp":1746628604,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时36分，Innate Pharma股票出现异动，股价急速拉升5.33%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Zyversa Therapeutics, Inc.涨幅较大，Theriva Biologics, Inc.、Zyversa Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1539.94%、1471.78%、179.67%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Theriva Biologics, Inc.，振幅分别为130.71%、58.00%、44.12%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507223645aa2c8614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507223645aa2c8614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2531586267","title":"Innate Pharma盘中异动 股价大涨8.61%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531586267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531586267?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:37","pubTimestamp":1745933857,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时37分，Innate Pharma股票出现波动，股价快速拉升8.61%。截至发稿，该股报2.27美元/股，成交量1.2798万股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.56%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213738a46c40f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213738a46c40f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2530281207","title":"Innate Pharma盘中异动 早盘急速上涨5.46%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281207?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:35","pubTimestamp":1745847304,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时35分，Innate Pharma股票出现异动，股价大幅拉升5.46%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1343.23%、320.06%、64.39%，振幅较大的相关个股有Protara Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.，振幅分别为18.15%、17.83%、16.55%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213504a46a8f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213504a46a8f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2529004336","title":"HC Wainwright & Co.：重申Innate Pharma评级，由买入调整至买入评级, 目标价由11.50美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529004336","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529004336?lang=zh_cn&edition=full","pubTime":"2025-04-24 19:13","pubTimestamp":1745493190,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Innate Pharma(IPHA.US)评级，由买入调整至买入评级, 目标价由11.50美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419171494e0edf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419171494e0edf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA"],"gpt_icon":0},{"id":"2529017332","title":"Innate Pharma盘中异动 临近收盘急速下跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529017332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529017332?lang=zh_cn&edition=full","pubTime":"2025-04-22 03:30","pubTimestamp":1745263814,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日03时30分，Innate Pharma股票出现波动，股价快速下跌5.58%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Transcode Therapeutics, Inc.、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1868.16%、1727.21%、1080.21%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Geovax Labs Inc C/Wts 29/09/2025、Aptevo Therapeutics Inc.，振幅分别为119.47%、111.18%、86.59%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422033014aa2c7534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422033014aa2c7534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2527422847","title":"Innate Pharma盘中异动 股价大涨5.41%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527422847?lang=zh_cn&edition=full","pubTime":"2025-04-16 03:30","pubTimestamp":1744745400,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日03时30分，Innate Pharma股票出现异动，股价大幅拉升5.41%。截至发稿，该股报2.00美元/股，成交量6258股，换手率0.01%，振幅3.16%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.47%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160330019738e8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160330019738e8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"gpt_icon":0},{"id":"2527143272","title":"Innate Pharma盘中异动 股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527143272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527143272?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:29","pubTimestamp":1744658955,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时29分，Innate Pharma股票出现波动，股价大幅上涨5.60%。Innate Pharma股票所在的生物技术行业中，整体涨幅为2.84%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Third Harmonic Bio, Inc.、天境生物涨幅较大，Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为810.03%、690.87%、345.27%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为78.58%、66.92%、66.29%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150329159737b8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150329159737b8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0},{"id":"2517294332","title":"Innate Pharma盘中异动 急速拉升8.04%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294332?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185025,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Innate Pharma股票出现异动，股价急速拉升8.04%。截至发稿，该股报2.15美元/股，成交量1.1293万股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2516530629","title":"Innate Pharma盘中异动 下午盘大幅下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516530629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516530629?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:04","pubTimestamp":1740773053,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时04分，Innate Pharma股票出现异动，股价大幅下挫5.32%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3254.22%、592.00%、392.49%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2514386234","title":"Innate Pharma盘中异动 大幅拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386234?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:54","pubTimestamp":1740668072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时54分，Innate Pharma股票出现异动，股价快速拉升5.31%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为486.33%、98.25%、86.97%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为59.93%、30.36%、21.99%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"gpt_icon":0},{"id":"2514851092","title":"Innate Pharma盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851092?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580520,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Innate Pharma股票出现波动，股价急速拉升5.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Immunoprecise Antibodies Ltd.、Channel Therapeutics Corporation涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为129.63%、96.91%、79.81%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":-0.0422},{"period":"1month","weight":-0.1333},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.0151},{"period":"1year","weight":-0.1679},{"period":"ytd","weight":-0.0526}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日，是一家生物技术公司，致力于发现，开发和商业化一流的治疗性抗体，这些抗体旨在利用免疫系统来治疗严重未满足医疗需求的肿瘤适应症。该公司在免疫肿瘤学的研究和开发方面拥有丰富的经验，是了解自然杀伤细胞或NK细胞生物学的先驱。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.033916},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.015647},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.017268},{"month":4,"riseRate":0.5,"avgChangeRate":0.010938},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.02182},{"month":6,"riseRate":0.5,"avgChangeRate":-0.084495},{"month":7,"riseRate":0.5,"avgChangeRate":0.017298},{"month":8,"riseRate":0.6,"avgChangeRate":0.003211},{"month":9,"riseRate":0.2,"avgChangeRate":-0.014742},{"month":10,"riseRate":0.4,"avgChangeRate":-0.007938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.014347},{"month":12,"riseRate":0.666667,"avgChangeRate":0.134382}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}